Results 231 to 240 of about 323,886 (359)
This research conducts an in‐depth investigation of cell‐type‐specific regulatory mechanisms underlying molecular and complex phenotypes through integrative analysis of multitissue single‐nucleus RNA sequencing, bulk RNA‐seq, and genome‐wide association study (GWAS) data in pigs.
Lijuan Chen +31 more
wiley +1 more source
Correction to: SLAMF6 regulates basal T cell receptor signaling and influences invariant natural killer T cell lineage diversity. [PDF]
europepmc +1 more source
Low-dose nivolumab for extranodal natural killer/T-cell lymphoma, nasal type. [PDF]
Maharaj S, Chang S.
europepmc +1 more source
Clinical applications of natural killer T cell–based immunotherapy for cancer
Shinichiro Motohashi, Toshinori Nakayama
openalex +2 more sources
This study describes a T cell surface engineering strategy that integrates polymer materials with tumor immunology, aiming to achieve broad‐spectrum anti‐tumor applications of glycopolymer‐engineered T (G‐T) cells via non‐genetic modification. Glycopolymer engineering generally modulates immune‐tumor crosstalk through specific cell‐cell interactions ...
Lihua Yao +8 more
wiley +1 more source
Orbital natural killer/T-cell lymphoma: a comprehensive case series and literature review. [PDF]
Li J +7 more
europepmc +1 more source
ABSTRACT Multiple myeloma (MM) is a hematologic malignancy driven by clonal expansion of malignant plasma cells. Despite the long‐term disease control achieved with immunotherapies in some patients, treatment resistance remains a major cause of disease relapse.
Huiyao Gu +15 more
wiley +1 more source
Central nervous system relapse of an extranodal natural killer/T-cell lymphoma. [PDF]
Chiriac R, Baseggio L, Golfier C.
europepmc +1 more source

